Does CLOMIPRAMINE Cause Dyslipidaemia? 78 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 78 reports of Dyslipidaemia have been filed in association with CLOMIPRAMINE (Clomipramine Hydrochloride). This represents 2.1% of all adverse event reports for CLOMIPRAMINE.
78
Reports of Dyslipidaemia with CLOMIPRAMINE
2.1%
of all CLOMIPRAMINE reports
0
Deaths
78
Hospitalizations
How Dangerous Is Dyslipidaemia From CLOMIPRAMINE?
Of the 78 reports, 78 (100.0%) required hospitalization, and 1 (1.3%) were considered life-threatening.
Is Dyslipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLOMIPRAMINE. However, 78 reports have been filed with the FAERS database.
What Other Side Effects Does CLOMIPRAMINE Cause?
Drug ineffective (561)
Toxicity to various agents (427)
Suicide attempt (375)
Off label use (271)
Coma (262)
Intentional overdose (237)
Weight increased (214)
Akathisia (204)
Obsessive-compulsive disorder (187)
Therapeutic product effect incomplete (184)
What Other Drugs Cause Dyslipidaemia?
OLANZAPINE (230)
ROSUVASTATIN (206)
ARIPIPRAZOLE (185)
METHOTREXATE (175)
QUETIAPINE (161)
ATORVASTATIN (155)
RISPERIDONE (154)
METFORMIN (151)
TACROLIMUS (149)
ZIPRASIDONE (149)
Which CLOMIPRAMINE Alternatives Have Lower Dyslipidaemia Risk?
CLOMIPRAMINE vs CLONAZEPAM
CLOMIPRAMINE vs CLONIDINE
CLOMIPRAMINE vs CLOPIDOGREL
CLOMIPRAMINE vs CLOPIDOGREL BESILATE
CLOMIPRAMINE vs CLOPIDOGREL BISULFATE